From October 1, 2023 to December 31, 2023, the company has repurchased 932,000 shares, representing 0.47% for CNY 10.08 million. With this, the company has completed the repurchase of 1,105,000 shares, representing 0.56% for CNY 13.4 million under the buyback announced on August 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.17 CNY | +2.08% | -7.69% | -20.91% |
1st Jan change | Capi. | |
---|---|---|
-20.91% | 460M | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- 002940 Stock
- News Zhejiang AngLiKang Pharmaceutical CO.,LTD.
- Tranche Update on Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s Equity Buyback Plan announced on August 31, 2023.